Literature DB >> 11737607

Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.

S G Adler1, S W Kang, S Feld, D R Cha, L Barba, L Striker, G Striker, B L Riser, J LaPage, C C Nast.   

Abstract

BACKGROUND: In patients with type 1 diabetes, some consider microalbuminuria to be a predictor of diabetic nephropathy while others believe it is an early feature of diabetic nephropathy.
METHODS: Levels of mRNAs that are of pathogenetic relevance in diabetic nephropathy were compared in glomeruli isolated from microalbuminuric and overtly proteinuric subjects and in control normoalbuminuric diabetic subjects and living renal transplant donors.
RESULTS: In subjects with microalbuminuria and overt proteinuria, glomerular mRNAs were virtually identical and approximately twofold higher for connective tissue growth factor (CTGF; P < 0.01) and collagen alpha2(IV) (P < 0.03) compared to living renal donors and normoalbuminuric patients. Glomerular glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels were not significantly different among the groups (P = 0.4). Weak but statistically significant correlations were noted between CTGF mRNA and albuminuria (assessed by rank), fractional mesangial surface area, and a composite renal biopsy index. Glomerular CTGF mRNA correlated inversely with creatinine clearance. Glomerular collagen alpha2(IV) mRNA levels correlated with albuminuria (by rank) and less strongly with fractional mesangial area.
CONCLUSION: To our knowledge, these data provide the first biochemical evidence demonstrating that the glomeruli of microalbuminuric patients and those with overt proteinuria do not differ significantly. The data support the concept that microalbuminuria is not "predictive" of diabetic nephropathy, but rather is an earlier point in the spectrum of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737607     DOI: 10.1046/j.1523-1755.2001.00073.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells.

Authors:  Xiaoyu Wang; Susan V McLennan; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2011-06-02       Impact factor: 5.782

Review 2.  The meaning of microalbuminuria in type 1 diabetes: the need for a new paradigm.

Authors:  S G Adler; C C Nast
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

3.  Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.

Authors:  Sharon G Adler; Sherwyn Schwartz; Mark E Williams; Carlos Arauz-Pacheco; Warren K Bolton; Tyson Lee; Dongxia Li; Thomas B Neff; Pedro R Urquilla; K Lea Sewell
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

4.  Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy.

Authors:  Amy Jayne McKnight; David A Savage; Chris C Patterson; Hugh R Brady; A Peter Maxwell
Journal:  J Hum Genet       Date:  2006-02-24       Impact factor: 3.172

5.  Diabetes increases renovascular impedance in patients with liver cirrhosis.

Authors:  Luisa Spadaro; Graziella Privitera; Giuseppe Fede; Orazio Magliocco; Maurizio Russello; Salvatore Piro; Agata Maria Rabuazzo; Francesco Purrello
Journal:  Intern Emerg Med       Date:  2015-04-12       Impact factor: 3.397

Review 6.  Gene expression in diabetic nephropathy.

Authors:  Daniela Hohenadel; Fokko J van der Woude
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

7.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

8.  Uteroplacental insufficiency causes a nephron deficit, modest renal insufficiency but no hypertension with ageing in female rats.

Authors:  Karen M Moritz; Marc Q Mazzuca; Andrew L Siebel; Amy Mibus; Debbie Arena; Marianne Tare; Julie A Owens; Mary E Wlodek
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

Review 9.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 10.  Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes.

Authors:  Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2018-02-06       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.